VOPROSY MEDITSINSKOI KHIMII (ISSN 0042-8809)

Activators and inhibitors of fibrinolysis in chronic glomerulonephritis and amyloidosis

   
Andreenko G.V., Polyantseva L.R., Bumblyte I.D., Podorolskaya L.V.
PubMed Id: 9254520
Year: 1996  Volume: 42  Issue: 4  Pages: 322-327
Functional activities of plasminogen activators (FPAA) and their inhibitors and plasminogen activators's (PA), antigen level were determined in 31 patients with chronic glomerulonephritis, 23 patients with amyloidosis and 15 healthy persons. High FPAA correlated with favourable prognosis of diseases, elevated PA antigen level and diminished alpha 1-antitrypsin, alpha 2-macroglobulin and antiactivator activities. There were decreased PA antigen level and increased inhibitor's activities in group with zero FPAA. Protein loaded functional probe demonstrated the presence of PA reserves in high FPAA patients and 'pathological proteolysis' in zero FPAA patients. The last phenomenon was likely connected to nonspecific proteases differed from PA.
Download PDF:  
Keywords: chronic glomerulonephritis, amyloidosis, regulators of limited proteolysis
Citation:

Andreenko, G. V., Polyantseva, L. R., Bumblyte, I. D., Podorolskaya, L. V. (1996). Activators and inhibitors of fibrinolysis in chronic glomerulonephritis and amyloidosis. Voprosy Meditsinskoi Khimii, 42(4), 322-327.
References  
 2002 (vol 48)
 2001 (vol 47)
 2000 (vol 46)
 1999 (vol 45)
 1998 (vol 44)
 1997 (vol 43)
 1996 (vol 42)
 1995 (vol 41)
 1994 (vol 40)
 1993 (vol 39)
 1992 (vol 38)
 1991 (vol 37)
 1990 (vol 36)
 1989 (vol 35)
 1988 (vol 34)
 1987 (vol 33)
 1986 (vol 32)
 1985 (vol 31)